Seibold F, Weber P, Schöning A, Mörk H, Goppel S, Scheurlen M
Medizinische Poliklinik, Universität Würzburg, Germany.
Eur J Gastroenterol Hepatol. 1996 Nov;8(11):1095-100. doi: 10.1097/00042737-199611000-00012.
A high frequency of perinuclear neutrophil antibodies (pANCA) has been described in patients with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC). We evaluated the presence of pANCA in chronic liver disease and compared the immunoglobulin G (IgG) subclasses of pANCA in inflammatory bowel disease with chronic liver disease. Since the antigen reacting with pANCA could not be determined, the antigenic role of various neutrophil antigens was evaluated.
Detection of pANCA and their IgG subclass was performed by immunofluorescence. One hundred and forty patients with chronic liver disease, 96 patients with inflammatory bowel disease and 40 healthy controls were tested for pANCA. pANCA positive and negative sera were evaluated for their reactivity with different neutrophil antigens in an enzyme-linked immunosorbent assay (ELISA) system.
pANCA were found in 8 of 23 patients (35%) with autoimmune hepatitis, in 6 of 21 patients (28%) with primary biliary cirrhosis (PBC), in 18 of 25 patients (72%) with PSC, in 3 of 48 patients (6%) with viral hepatitis, in 30 of 48 patients (62%) with UC, and in 2 of 48 patients (4%) with Crohn's disease. All 20 patients with alcoholic liver disease and 40 healthy controls were negative for pANCA. In contrast to the patients with UC who had 83% IgG1 and only 13% IgG3 antibodies, patients with PSC and PBC had an overexpression of IgG3 antibodies (PSC: 50% IgG3; PBC: 67% IgG3). A proportion of pANCA positive sera recognized lactoferrin, myeloperoxidase, cathepsin G, laminarase and alpha 1-antitrypsin.
pANCA is not present only in patients with UC but in autoimmune liver diseases such as PSC, autoimmune hepatitis and PBC. Considering the IgG subclass of pANCA, the antibody response of patients with UC is different from patients with liver disease. No unique pANCA specific antigen could be detected, so heterogeneity of pANCA has to be considered.
溃疡性结肠炎(UC)和原发性硬化性胆管炎(PSC)患者中已报道有高频率的核周中性粒细胞抗体(pANCA)。我们评估了慢性肝病患者中pANCA的存在情况,并比较了炎症性肠病与慢性肝病患者中pANCA的免疫球蛋白G(IgG)亚类。由于与pANCA反应的抗原无法确定,因此评估了各种中性粒细胞抗原的抗原作用。
采用免疫荧光法检测pANCA及其IgG亚类。对140例慢性肝病患者、96例炎症性肠病患者和40例健康对照者进行pANCA检测。在酶联免疫吸附测定(ELISA)系统中,评估pANCA阳性和阴性血清与不同中性粒细胞抗原的反应性。
23例自身免疫性肝炎患者中有8例(35%)检测到pANCA,21例原发性胆汁性肝硬化(PBC)患者中有6例(28%),25例PSC患者中有18例(72%),48例病毒性肝炎患者中有3例(6%),48例UC患者中有30例(62%),48例克罗恩病患者中有2例(4%)。所有20例酒精性肝病患者和40例健康对照者的pANCA均为阴性。与UC患者中IgG1抗体占83%而IgG3抗体仅占13%不同,PSC和PBC患者的IgG3抗体过度表达(PSC:50% IgG3;PBC:67% IgG3)。一部分pANCA阳性血清可识别乳铁蛋白、髓过氧化物酶、组织蛋白酶G、层粘连蛋白和α1-抗胰蛋白酶。
pANCA不仅存在于UC患者中,也存在于自身免疫性肝病如PSC、自身免疫性肝炎和PBC患者中。考虑到pANCA的IgG亚类,UC患者的抗体反应与肝病患者不同。未检测到独特的pANCA特异性抗原,因此必须考虑pANCA的异质性。